Technical Analysis for CDAK - Codiak BioSciences, Inc.

Grade Last Price % Change Price Change
grade D 9.62 2.01% 0.19
CDAK closed up 2.01 percent on Friday, October 23, 2020, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical CDAK trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
New 52 Week Closing Low Bearish 2.01%
Hot IPO Pullback Bullish Swing Setup 2.01%
NR7 Range Contraction 2.01%
Inside Day Range Contraction 2.01%
Down 3 Days in a Row Weakness 2.01%
New 52 Week Closing Low Bearish -1.33%
Hot IPO Pullback Bullish Swing Setup -1.33%
Older End-of-Day Gignals for CDAK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Reversed from Up 3 days ago
Up 2% 3 days ago
Gap Up Closed 3 days ago
Down 3% 3 days ago
Down 2 % 3 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
Biopharmaceutical Life Sciences Biology Diseases Disease Infectious Disease Exosome Vesicles Neuromuscular Disease

Is CDAK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.4
52 Week Low 9.05
Average Volume 407,993
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 0.00
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Fundamentals Value
Market Cap 178.88 Million
Num Shares 18.6 Million
EPS
Price-to-Sales 198.77
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.42
Resistance 3 (R3) 10.34 10.00 10.28
Resistance 2 (R2) 10.00 9.80 10.04 10.24
Resistance 1 (R1) 9.81 9.67 9.91 9.89 10.19
Pivot Point 9.47 9.47 9.52 9.51 9.47
Support 1 (S1) 9.28 9.27 9.38 9.36 9.05
Support 2 (S2) 8.94 9.14 8.98 9.00
Support 3 (S3) 8.75 8.94 8.96
Support 4 (S4) 8.83